This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A First Report of Their Relation to Drug Use With Special Reference to Analgesics

The International Agranulocytosis and Aplastic Anemia Study

JAMA. 1986;256(13):1749-1757.

Abstract
The risks of agranulocytosis and aplastic anemia in relation to analgesic drug use were evaluated in a population-based case-control study conducted in Europe and Israel. Analgesic use in the week before the onset of illness was compared between 221 cases of agranulocytosis and 1425 hospital controls. Analgesics significantly associated with agranulocytosis were dipyrone (metamizol sodium), indomethacin, and butazones (phenylbutazone and oxyphenbutazone). For dipyrone, the rate ratio estimate was 23.7 in Ulm, West Germany, West Berlin, and Barcelona, Spain, and the estimated excess risk for any exposure in a one-week period was 1.1 per million. In Israel and Budapest, Hungary, where the rate ratio estimate was 0.8, there was no evidence of excess risk. In all of the regions combined, the rate ratio estimates were 8.9 for indomethacin and 3.8 for butazones, with excess risk estimates of 0.6 and 0.2 per million, respectively. Analgesic use 29 to 180 days before admission was compared between 113 cases of aplastic anemia and 1724 controls. Indomethacin (rate ratio estimate, 12.7), diclofenac sodium (8.8), and butazones (8.7) were significantly associated with aplastic anemia, with estimated excess risks for any exposure in a five-month period of 10.1, 6.8, and 6.6 per million, respectively.

(JAMA 1986;256:1749-1757)

Footnotes
Reprint requests to Drug Epidemiology Unit, Boston University School of Medicine, 1371 Beacon St, Brookline, MA 02146 (Dr Shapiro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic
Hinz et al.
FASEB J. 2007;21:2343-2351.
ABSTRACT | FULL TEXT  

Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn et al.
ANN INTERN MED 2007;146:657-665.
ABSTRACT | FULL TEXT  

Successful desensitization to antithymocyte globulin in a child with aplastic anemia.
Hall and Hagemann
Am J Health Syst Pharm 2006;63:1633-1636.
FULL TEXT  

Risk of Clozapine-Associated Agranulocytosis and Mandatory White Blood Cell Monitoring
Schulte
The Annals of Pharmacotherapy 2006;40:683-688.
ABSTRACT | FULL TEXT  

Population-Based Drug-Induced Agranulocytosis
Ibanez et al.
Arch Intern Med 2005;165:869-874.
ABSTRACT | FULL TEXT  

Developmental effects of propyphenazone in analgesic and antipyretic combination with caffeine or paracetamol
Burdan
Hum Exp Toxicol 2004;23:235-244.
ABSTRACT  

Invited Commentary: Imaging Infection in Patients with Agranulocytosis
Schauwecker
JNM 2002;43:925-927.
FULL TEXT  

Antipyretic Effects of Dipyrone Versus Ibuprofen Versus Acetaminophen in Children: Results of a Multinational, Randomized, Modified Double-Blind Study
Wong et al.
CLIN PEDIATR 2001;40:313-324.
ABSTRACT  

Are We Losing Good Drugs?
Berlin
CLIN PEDIATR 2001;40:325-326.
 

Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality
Paradiso-Hardy et al.
CMAJ 2000;163:1441-1448.
ABSTRACT | FULL TEXT  

Hypersensitivity to pyrazolones
Levy
Thorax 2000;55:72S-74.
FULL TEXT  

Survey of unlicensed and off label drug use in paediatric wards in European countries
Conroy et al.
BMJ 2000;320:79-82.
ABSTRACT | FULL TEXT  

A Population-Based Case-Cohort Study of Drug-Associated Agranulocytosis
van der Klauw et al.
Arch Intern Med 1999;159:369-374.
ABSTRACT | FULL TEXT  

Oxidation of a Metabolite of Indomethacin (Desmethyldeschlorobenzoylindomethacin) to Reactive Intermediates by Activated Neutrophils, Hypochlorous Acid, and the Myeloperoxidase System
Ju and Uetrecht
Drug Metab. Dispos. 1998;26:676-680.
ABSTRACT | FULL TEXT  

Haematological safety of antipsychotic drugs
King and Wager
J Psychopharmacol 1998;12:283-288.
ABSTRACT  

Misuse of Veterinary Phenylbutazone
Carpenter and McDonnell
Arch Intern Med 1995;155:1229-1231.
ABSTRACT  

NSAIDs: Are There Any Differences?
Kaplan and Swain
Arch Fam Med 1993;2:1167-1174.
ABSTRACT  

Nonsteroidal Anti-inflammatory Drugs and Neutropenia
Strom et al.
Arch Intern Med 1993;153:2119-2124.
ABSTRACT  

Descriptive Epidemiology of Agranulocytosis
Strom et al.
Arch Intern Med 1992;152:1475-1480.
ABSTRACT  

A Population-Based Study of Stevens-Johnson Syndrome: Incidence and Antecedent Drug Exposures
Strom et al.
Arch Dermatol 1991;127:831-838.
ABSTRACT  

Incidence of Toxic Epidermal Necrolysis in Italy
Naldi et al.
Arch Dermatol 1990;126:1103-1104.
ABSTRACT  

Colony-Stimulating Factor and Drug-Induced Agranulocytosis
Delannoy and Gehenot
ANN INTERN MED 1989;110:942-943.
ABSTRACT  

Anti-infective Drug Use in Relation to the Risk of Agranulocytosis and Aplastic Anemia: A Report From the International Agranulocytosis and Aplastic Anemia Study
Arch Intern Med 1989;149:1036-1040.
ABSTRACT  

Pentoxifylline and Aplastic Anemia
MASS et al.
ANN INTERN MED 1987;107:427-428.
ABSTRACT  

Analgesic Use, Agranulocytosis, and Aplastic Anemia
van Dijke
JAMA 1987;257:2590-2590.
ABSTRACT  

Analgesic Use, Agranulocytosis, and Aplastic Anemia
Feldmann et al.
JAMA 1987;257:2590-2591.
ABSTRACT  

Analgesic Risks and Pharmacoepidemiology
Faich
JAMA 1986;256:1788-1788.
ABSTRACT